Attacking Cancer With Specific Anti-Tumor Pathways
October 19, 2009 16:10 ET
|
Cellceutix Corporation
BEVERLY, Mass., Oct. 19, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX) today announced that data recently presented by the Company at the American Association for Cancer Research (AACR)...
Cellceutix Poster Presented At American Association for Cancer Research; Dr. Menon Selected for Expert Panel
October 13, 2009 07:00 ET
|
Cellceutix Corporation
Kevetrin(TM) Shows Excellent Activity in Animal Models of Drug
Resistant Lung Cancer With Less Cytotoxicity Than Paclitaxel
Cellceutix of Beverly, MA, to Pursue Development for...
Cellceutix Compound Shows Significant Effect On Psoriasis
October 05, 2009 16:01 ET
|
Cellceutix Corporation
BEVERLY, Mass., Oct. 5, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX) today announced that it has successfully completed a study with its proprietary compound, KM-133, in a human...
Cellceutix Meets With One of the World's Largest Pharmaceutical Companies At Partnering Meeting
September 23, 2009 08:00 ET
|
Cellceutix Corporation
BEVERLY, Mass., Sept. 23, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), an emerging bio-pharmaceutical company in the business of developing small-molecule therapies in areas of unmet...
Cellceutix's Kevetrin(TM) Demonstrates Significant Delay of Tumor Growth in Drug Resistant Breast Cancer
September 21, 2009 16:00 ET
|
Cellceutix Corporation
* Breast Cancer is 2nd Highest Cause of Cancer Deaths in Women
* 62+% Tumor Growth Delay vs. paclitaxel, 52% vs. cisplatin, in Animal
Models
* 79+% Tumor Volume Reduction vs. paclitaxel,...
Cellceutix Announces Acquisition of New Compound With High Blood Pressure Lowering Properties
August 25, 2009 07:30 ET
|
Cellceutix Corporation
BEVERLY, Mass., Aug. 25, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), a bio-pharmaceutical company in the business of developing small-molecule therapies in areas of unmet medical...
Cellceutix Signs Agreement for Kevetrin(tm) API
August 17, 2009 08:00 ET
|
Cellceutix Corporation
BEVERLY, Mass., Aug. 17, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), a bio-pharmaceutical company in the business of developing small-molecule therapies in areas of unmet medical...
Cellceutix's Cancer Drug Shows No Significant Indications of Toxicity
July 22, 2009 07:30 ET
|
Cellceutix Corporation
BEVERLY, Mass., July 22, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX), announced today that it has completed acute toxicity studies in mice and rats with its proprietary pharmaceutical...
Cellceutix Announces Dr. Samuel Danishefsky Joins Its Scientific Advisory Board
July 14, 2009 17:41 ET
|
Cellceutix Corporation
BEVERLY, Mass., July 14, 2009 (GLOBE NEWSWIRE) -- Cellceutix Corporation (OTCBB:CTIX) announced today that Dr. Samuel Danishefsky has agreed to serve on the Cellceutix Scientific Advisory Board...
Cellceutix Announces Kevetrin(tm) Animal Model Testing Success Against Multi-Drug Resistant Lung Cancer Cell Lines
July 13, 2009 07:00 ET
|
Cellceutix Corporation
* 90+% Tumor Size Reduction on Lung Cancer Cell Lines A549
and NCI-H1975
* 100+% Tumor Growth Delay on Lung Cancer Cell Lines A549
...